Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells - Potential for paracrine/autocrine effects

被引:125
作者
Venugopal, SK [1 ]
Devaraj, S [1 ]
Jialal, I [1 ]
机构
[1] Univ Calif Davis, Med Ctr, Lab Atherosclerosis & Metab Res, Dept Pathol & Lab Med, Sacramento, CA 95817 USA
关键词
D O I
10.1016/S0002-9440(10)62345-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
C-reactive protein (CRP) is a risk marker for cardiovascular events in apparently healthy persons. Cogent data show that, aside from the liver, CRP is produced in atherosclerotic lesions, kidney, neurons, and alveolar macrophages. Because several proatherogenic effects of CRP have been documented in endothelial cells, we examined human aortic endothelial cells (HAEC) for CRP production. We detected the presence of CRP mRNA by RT-PCR and in situ hybridization, intracellular protein by Western blot and secreted protein by ELISA. Coincubation with the cytokines; interleukin (IL)-1, IL-6, and tumor necrosis factor alone and in combination showed that the most potent agonist for CRP production from HAEC is the combination of IL-1 and IL-6 (P < 0.05). To mimic the in vivo situation, we examined whether vascular smooth muscle cell (VSMC) and/or macrophage conditioned media (MCM) could augment CRP production by HAEC. While VSMC-conditioned media had no effect, incubation with MCM resulted in a significant twofold increase in the synthesis of both intracellular and secreted CRP (P < 0.05). The effect of MCM could be reversed by inhibiting both IL-1 and IL-6. Thus, stimulated synthesis and secretion of CRP by cells in the atherosclerotic lesion by paracrine/autocrine loops could result in local concentrations of CRP far in excess of plasma concentrations and could contribute to proinflammatory, proatherogenic effects.
引用
收藏
页码:1265 / 1271
页数:7
相关论文
共 36 条
[1]   Transactivation of c-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer finding protein β (C/EBPβ) and Rel p50 [J].
Agrawal, A ;
Cha-Molstad, H ;
Samols, D ;
Kushner, I .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2378-2384
[2]   C-reactive protein [J].
Black, S ;
Kushner, I ;
Samols, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48487-48490
[3]   Elevated C-reactive protein values and atherosclerosis in sudden coronary death - Association with different pathologies [J].
Burke, AP ;
Tracy, RP ;
Kolodgie, F ;
Malcom, GT ;
Zieske, A ;
Kutys, R ;
Pestaner, J ;
Smialek, J ;
Virmani, R .
CIRCULATION, 2002, 105 (17) :2019-2023
[4]   Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells [J].
Calabró, P ;
Willerson, JT ;
Yeh, ETH .
CIRCULATION, 2003, 108 (16) :1930-1932
[5]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[6]  
Dong Q, 1996, J IMMUNOL, V156, P4815
[7]   Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].
Fichtlscherer, S ;
Rosenberger, G ;
Walter, DH ;
Breuer, S ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2000, 102 (09) :1000-1006
[8]  
GANAPATHI MK, 1988, J IMMUNOL, V141, P564
[9]  
GANAPATHI MK, 1991, J IMMUNOL, V147, P1261
[10]   DUAL CONTROL OF C-REACTIVE PROTEIN GENE-EXPRESSION BY INTERLEUKIN-1 AND INTERLEUKIN-6 [J].
GANTER, U ;
ARCONE, R ;
TONIATTI, C ;
MORRONE, G ;
CILIBERTO, G .
EMBO JOURNAL, 1989, 8 (12) :3773-3779